These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

189 related articles for article (PubMed ID: 34304250)

  • 1. DIF-1 inhibits growth and metastasis of triple-negative breast cancer through AMPK-mediated inhibition of the mTORC1-S6K signaling pathway.
    Seto-Tetsuo F; Arioka M; Miura K; Inoue T; Igawa K; Tomooka K; Takahashi-Yanaga F; Sasaguri T
    Oncogene; 2021 Sep; 40(37):5579-5589. PubMed ID: 34304250
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Differentiation-inducing factor-1 suppresses cyclin D1-induced cell proliferation of MCF-7 breast cancer cells by inhibiting S6K-mediated signal transducer and activator of transcription 3 synthesis.
    Tetsuo F; Arioka M; Miura K; Kai M; Kubo M; Igawa K; Tomooka K; Takahashi-Yanaga F; Nishimura F; Sasaguri T
    Cancer Sci; 2019 Dec; 110(12):3761-3772. PubMed ID: 31553107
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Ciclopirox olamine inhibits mTORC1 signaling by activation of AMPK.
    Zhou H; Shang C; Wang M; Shen T; Kong L; Yu C; Ye Z; Luo Y; Liu L; Li Y; Huang S
    Biochem Pharmacol; 2016 Sep; 116():39-50. PubMed ID: 27396756
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Halogen-Substituted Derivatives of
    Totsuka K; Makioka Y; Iizumi K; Takahashi K; Oshima Y; Kikuchi H; Kubohara Y
    Biomolecules; 2019 Jun; 9(7):. PubMed ID: 31261818
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Vascular tumors have increased p70 S6-kinase activation and are inhibited by topical rapamycin.
    Du W; Gerald D; Perruzzi CA; Rodriguez-Waitkus P; Enayati L; Krishnan B; Edmonds J; Hochman ML; Lev DC; Phung TL
    Lab Invest; 2013 Oct; 93(10):1115-27. PubMed ID: 23938603
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Differentiation-inducing factor-1 reduces lipopolysaccharide-induced vascular cell adhesion molecule-1 by suppressing mTORC1-S6K signaling in vascular endothelial cells.
    Arioka M; Seto-Tetsuo F; Inoue T; Miura K; Ishikane S; Igawa K; Tomooka K; Takahashi-Yanaga F; Sasaguri T
    Life Sci; 2023 Dec; 335():122278. PubMed ID: 37981227
    [TBL] [Abstract][Full Text] [Related]  

  • 7. CCL2 is a negative regulator of AMP-activated protein kinase to sustain mTOR complex-1 activation, survivin expression, and cell survival in human prostate cancer PC3 cells.
    Roca H; Varsos ZS; Pienta KJ
    Neoplasia; 2009 Dec; 11(12):1309-17. PubMed ID: 20019839
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A possible linkage between AMP-activated protein kinase (AMPK) and mammalian target of rapamycin (mTOR) signalling pathway.
    Kimura N; Tokunaga C; Dalal S; Richardson C; Yoshino K; Hara K; Kemp BE; Witters LA; Mimura O; Yonezawa K
    Genes Cells; 2003 Jan; 8(1):65-79. PubMed ID: 12558800
    [TBL] [Abstract][Full Text] [Related]  

  • 9. LLY17, a novel small molecule STAT3 inhibitor induces apoptosis and suppresses cell migration and tumor growth in triple-negative breast cancer.
    Pan L; Chen X; Fu S; Yu W; Li C; Wang T; Lo HW; Lin J
    Breast Cancer Res Treat; 2020 May; 181(1):31-41. PubMed ID: 32240456
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Ascofuranone suppresses invasion and F-actin cytoskeleton organization in cancer cells by inhibiting the mTOR complex 1 signaling pathway.
    Jeong YJ; Hwang SK; Magae J; Chang YC
    Cell Oncol (Dordr); 2020 Oct; 43(5):793-805. PubMed ID: 32488849
    [TBL] [Abstract][Full Text] [Related]  

  • 11. PF-4708671 activates AMPK independently of p70S6K1 inhibition.
    Vainer GW; Saada A; Kania-Almog J; Amartely A; Bar-Tana J; Hertz R
    PLoS One; 2014; 9(9):e107364. PubMed ID: 25202971
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Periplocin inhibits the growth of pancreatic cancer by inducing apoptosis via AMPK-mTOR signaling.
    Xie G; Sun L; Li Y; Chen B; Wang C
    Cancer Med; 2021 Jan; 10(1):325-336. PubMed ID: 33231372
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Induction of AMPK activation by N,N'-diarylurea FND-4b decreases growth and increases apoptosis in triple negative and estrogen-receptor positive breast cancers.
    Johnson J; Rychahou P; Sviripa VM; Weiss HL; Liu C; Watt DS; Evers BM
    PLoS One; 2019; 14(3):e0209392. PubMed ID: 30875375
    [TBL] [Abstract][Full Text] [Related]  

  • 14. AMPD1 regulates mTORC1-p70 S6 kinase axis in the control of insulin sensitivity in skeletal muscle.
    Tandelilin AA; Hirase T; Hudoyo AW; Cheng J; Toyama K; Morisaki H; Morisaki T
    BMC Endocr Disord; 2015 Mar; 15():11. PubMed ID: 25887856
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Tanshinone IIA induces autophagic cell death via activation of AMPK and ERK and inhibition of mTOR and p70 S6K in KBM-5 leukemia cells.
    Yun SM; Jung JH; Jeong SJ; Sohn EJ; Kim B; Kim SH
    Phytother Res; 2014 Mar; 28(3):458-64. PubMed ID: 23813779
    [TBL] [Abstract][Full Text] [Related]  

  • 16. MicroRNA-451 regulates AMPK/mTORC1 signaling and fascin1 expression in HT-29 colorectal cancer.
    Chen MB; Wei MX; Han JY; Wu XY; Li C; Wang J; Shen W; Lu PH
    Cell Signal; 2014 Jan; 26(1):102-9. PubMed ID: 23899558
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Patient-derived xenografts of triple-negative breast cancer reproduce molecular features of patient tumors and respond to mTOR inhibition.
    Zhang H; Cohen AL; Krishnakumar S; Wapnir IL; Veeriah S; Deng G; Coram MA; Piskun CM; Longacre TA; Herrler M; Frimannsson DO; Telli ML; Dirbas FM; Matin AC; Dairkee SH; Larijani B; Glinsky GV; Bild AH; Jeffrey SS
    Breast Cancer Res; 2014 Apr; 16(2):R36. PubMed ID: 24708766
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Zerumbone suppresses the motility and tumorigenecity of triple negative breast cancer cells via the inhibition of TGF-β1 signaling pathway.
    Kim S; Lee J; Jeon M; Lee JE; Nam SJ
    Oncotarget; 2016 Jan; 7(2):1544-58. PubMed ID: 26637807
    [TBL] [Abstract][Full Text] [Related]  

  • 19. mTORC1 is a target of nordihydroguaiaretic acid to prevent breast tumor growth in vitro and in vivo.
    Zhang Y; Xu S; Lin J; Yao G; Han Z; Liang B; Zou Z; Chen Z; Song Q; Dai Y; Gao T; Liu A; Bai X
    Breast Cancer Res Treat; 2012 Nov; 136(2):379-88. PubMed ID: 23053656
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Co-inhibition of mTORC1, HDAC and ESR1α retards the growth of triple-negative breast cancer and suppresses cancer stem cells.
    Sulaiman A; McGarry S; Lam KM; El-Sahli S; Chambers J; Kaczmarek S; Li L; Addison C; Dimitroulakos J; Arnaout A; Nessim C; Yao Z; Ji G; Song H; Liu S; Xie Y; Gadde S; Li X; Wang L
    Cell Death Dis; 2018 Jul; 9(8):815. PubMed ID: 30050079
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.